{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:42:07Z","timestamp":1793731327551,"version":"4.6.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2500200"],"award-info":[{"award-number":["2021YFC2500200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2500204"],"award-info":[{"award-number":["2021YFC2500204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Technologies R&D Program of Guangdong Province","award":["2023B1111030004"],"award-info":[{"award-number":["2023B1111030004"]}]},{"name":"Guangdong Provincial Clinical Research","award":["2020B1111170013"],"award-info":[{"award-number":["2020B1111170013"]}]},{"DOI":"10.13039\/501100012176","name":"Program of Introducing Talents of Discipline to Universities","doi-asserted-by":"crossref","award":["D18005"],"award-info":[{"award-number":["D18005"]}],"id":[{"id":"10.13039\/501100012176","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82030022"],"award-info":[{"award-number":["82030022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900626"],"award-info":[{"award-number":["81900626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>It is uncertain whether the discontinuation of renin-angiotensin system (RAS) improves prognosis among patients during an episode of hospital-acquired AKI.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Discontinuation of RAS inhibitors within 2 days after AKI was associated with lower risk of all-cause mortality as compared with continuation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Temporary discontinuation of RAS inhibitors during AKI episodes may improve outcomes in long-term users.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renin-angiotensin system inhibitors (RASis) are widely used among patients with cardiovascular disease, diabetes, and CKD, which are high-risk populations for AKI. Evidence for the optimal management of RASi during an episode of AKI is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multidatabase cohort study using sequential target trial emulation framework from the China Renal Data System and Medical Information Mart for Intensive Care IV (MIMIC-IV) databases. Adult patients with hospital-acquired AKI who had been receiving angiotensin-converting enzyme inhibitors or angiotensin receptor blockers treatment for at least 90 days were included. The primary outcomes were 30- and 180-day all-cause mortality. Adjusted cumulative incidences and risk differences were estimated using weighted pooled logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 27,003 person-trials were identified from the China Renal Data System database (median [interquartile range] age, 70 [58\u201378] years; 12,972 [60%] male) and the MIMIC-IV database (median [interquartile range] age, 73 [63\u201382] years; 2825 [53%] male). The adjusted cumulative incidence of 30-day all-cause mortality was lower among person-trials with RASi discontinuation within 2 days after the hospital-acquired AKI than continuation (4.36% versus 5.91%), with a risk difference of \u22121.55% (95% confidence interval, \u22122.43% to \u22120.55%). Discontinuation of RASi was consistently associated with lower risk of all-cause mortality in the MIMIC-IV database, with similar beneficial associations observed across stratified analyses and multiple sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, stopping RASi within the first 2 days of AKI detection was associated with a lower risk of all-cause mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000775","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:02:54Z","timestamp":1750248174000},"page":"2410-2420","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality"],"prefix":"10.1681","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-7909","authenticated-orcid":false,"given":"Sheng","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1720-6788","authenticated-orcid":false,"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3085-909X","authenticated-orcid":false,"given":"Licong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-9484","authenticated-orcid":false,"given":"Ruixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-5211","authenticated-orcid":false,"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-7418","authenticated-orcid":false,"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CRDS Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"10","key":"B1-20260114","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"B2-20260114","doi-asserted-by":"crossref","first-page":"j4","DOI":"10.1136\/bmj.j4","article-title":"Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials","volume":"356","author":"Bangalore","year":"2017","journal-title":"BMJ."},{"issue":"14","key":"B3-20260114","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction","volume":"67","author":"Evans","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"3S","key":"B4-20260114","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"B5-20260114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2215\/CJN.13801119","article-title":"Renin-angiotensin system blockade after acute kidney injury: the plot thickens","volume":"15","author":"Menez","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"B6-20260114","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med."},{"issue":"5","key":"B7-20260114","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.kint.2020.08.022","article-title":"Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality","volume":"99","author":"Siew","year":"2021","journal-title":"Kidney Int."},{"issue":"10","key":"B8-20260114","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.0000000000000196","article-title":"Renin-angiotensin-Aldosterone system blockade after AKI with or without recovery among US veterans with diabetic kidney disease","volume":"34","author":"Murphy","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B9-20260114","article-title":"TrialEmulation: an R package to emulate target trials for causal analysis of observational time-to-event data","volume":"55","author":"Su","year":"2024","journal-title":"J Stat Softw."},{"issue":"8","key":"B10-20260114","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol."},{"issue":"21","key":"B11-20260114","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1056\/NEJMp2407586","article-title":"\u201cTarget trial emulation\u201d for observational studies \u2013 potential and pitfalls","volume":"391","author":"Hubbard","year":"2024","journal-title":"New Engl J Med."},{"issue":"5","key":"B12-20260114","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/M20-6739","article-title":"Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19","volume":"174","author":"Al-Samkari","year":"2021","journal-title":"Ann Intern Med."},{"issue":"6","key":"B13-20260114","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/M23-1874","article-title":"Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease","volume":"177","author":"Yen","year":"2024","journal-title":"Ann Intern Med."},{"issue":"1","key":"B14-20260114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/EDE.0000000000001808","article-title":"A structural description of biases that generate immortal time","volume":"36","author":"Hern\u00e1n","year":"2025","journal-title":"Epidemiology."},{"issue":"21","key":"B15-20260114","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1503\/cmaj.230093","article-title":"Statin initiation and risk of incident kidney disease in patients with diabetes","volume":"195","author":"Zhou","year":"2023","journal-title":"CMAJ."},{"issue":"7","key":"B16-20260114","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1681\/ASN.0000000000000125","article-title":"Detecting neonatal AKI by serum cystatin C","volume":"34","author":"Xu","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"B17-20260114","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7326\/M24-0178","article-title":"Comparative effectiveness and safety of atorvastatin versus rosuvastatin: a multi-database cohort study","volume":"177","author":"Zhou","year":"2024","journal-title":"Ann Intern Med."},{"issue":"1","key":"B18-20260114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13613-021-00830-8","article-title":"Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database","volume":"11","author":"Zhou","year":"2021","journal-title":"Ann Intensive Care."},{"issue":"1","key":"B20-20260114","first-page":"19","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Section 2: AKI Definition","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)."},{"issue":"9","key":"B21-20260114","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2215\/CJN.02140215","article-title":"Epidemiology and clinical correlates of AKI in Chinese hospitalized adults","volume":"10","author":"Xu","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B22-20260114","doi-asserted-by":"crossref","first-page":"e210775","DOI":"10.1001\/jamanetworkopen.2021.0775","article-title":"Association of ibuprofen prescription with acute kidney injury among hospitalized children in China","volume":"4","author":"Su","year":"2021","journal-title":"JAMA Netw Open."},{"issue":"6","key":"B23-20260114","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1164\/rccm.201604-0799OC","article-title":"Recovery after acute kidney injury","volume":"195","author":"Kellum","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"issue":"10204","key":"B24-20260114","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet."},{"issue":"1","key":"B25-20260114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41597-022-01411-5","article-title":"VitalDB, a high-fidelity multi-parameter vital signs database in surgical patients","volume":"9","author":"Lee","year":"2022","journal-title":"Sci Data."},{"issue":"5","key":"B26-20260114","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"issue":"12","key":"B27-20260114","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1681\/ASN.2021070988","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease","volume":"32","author":"Delgado","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B28-20260114","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology."},{"issue":"12","key":"B29-20260114","doi-asserted-by":"crossref","first-page":"e1185","DOI":"10.1097\/CCM.0000000000004588","article-title":"Effect of renin-angiotensin-aldosterone system blockade on long-term outcomes in postacute kidney injury patients with hypertension","volume":"48","author":"Yang","year":"2020","journal-title":"Crit Care Med."},{"issue":"1","key":"B30-20260114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.05800519","article-title":"Renin-angiotensin system blockade after acute kidney injury (AKI) and risk of recurrent AKI","volume":"15","author":"Hsu","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B31-20260114","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00134-018-5160-6","article-title":"Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury","volume":"44","author":"Gayat","year":"2018","journal-title":"Intensive Care Med."},{"issue":"1","key":"B32-20260114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-020-01659-x","article-title":"Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care","volume":"18","author":"Bidulka","year":"2020","journal-title":"BMC Med."},{"issue":"12","key":"B33-20260114","doi-asserted-by":"crossref","first-page":"e012690","DOI":"10.1136\/bmjopen-2016-012690","article-title":"Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study","volume":"6","author":"Mansfield","year":"2016","journal-title":"BMJ Open."},{"issue":"2","key":"B34-20260114","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.kint.2020.04.020","article-title":"Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference","volume":"98","author":"Ostermann","year":"2020","journal-title":"Kidney Int."},{"issue":"5","key":"B35-20260114","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s40620-022-01497-5","article-title":"Sick day management in people with chronic kidney disease: a scoping review","volume":"36","author":"Duong","year":"2023","journal-title":"J Nephrol."},{"issue":"9","key":"B36-20260114","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.xkme.2022.100527","article-title":"Medication holds in CKD during acute volume-depleting illnesses: a randomized controlled trial of a \u201csick-day\u201d protocol","volume":"4","author":"Fink","year":"2022","journal-title":"Kidney Med."},{"issue":"9","key":"B37-20260114","doi-asserted-by":"crossref","first-page":"100491","DOI":"10.1016\/j.xkme.2022.100491","article-title":"Sick Day medication guidance for people with diabetes, kidney disease, or cardiovascular disease: a systematic scoping review","volume":"4","author":"Watson","year":"2022","journal-title":"Kidney Med."},{"issue":"4s","key":"B38-20260114","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"11","key":"B39-20260114","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/ndt\/gft405","article-title":"Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery","volume":"28","author":"Coca","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B40-20260114","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41467-023-39474-6","article-title":"Predicting in-hospital outcomes of patients with acute kidney injury","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun."},{"issue":"10002","key":"B41-20260114","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0140-6736(15)00344-X","article-title":"Acute kidney injury in China: a cross-sectional survey","volume":"386","author":"Yang","year":"2015","journal-title":"Lancet."},{"issue":"11","key":"B42-20260114","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:56:38Z","timestamp":1786132598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000775"}},"subtitle":["Target Trial Emulation Studies"],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000775","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"2025-02-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}